Island Pharmaceuticals Limited (ASX:ILA)
Australia flag Australia · Delayed Price · Currency is AUD
0.4700
+0.0050 (1.08%)
Aug 11, 2026, 3:49 PM AEST

Island Pharmaceuticals Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
0.060.121.26---
Revenue Growth
-47.14%-90.57%----
Gross Profit
-1.99-1.29-1.01-1.14--
Operating Income
-7.36-3.96-2.86-2.91-2.81-2.14
Net Income
-7.2-3.92-2.86-2.83-2.61-2.13
Earnings Per Share
-0.03-0.02-0.03-0.03-0.03-0.11
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
6.877.251.6624.796.46
Total Debt
--0.42---
Net Cash (Debt)
6.877.251.2424.796.46
Net Cash Growth
-5.27%485.58%-38.03%-58.26%-25.90%646064300.00%
Net Cash Per Share
0.030.040.010.020.060.35

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-3.67-2.77-3.16-2.7-1.88-0.94
Free Cash Flow
-3.67-2.77-3.16-2.7-1.88-0.94
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
---80.14%---
Operating Margin
-11715.94%-3326.06%-227.00%---
Pretax Margin
-11452.57%-3296.73%-227.04%---
Profit Margin
-11452.57%-3296.73%-227.04%---

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
2212.87277.977.74---